Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 1998 March;50(1) > Minerva Urologica e Nefrologica 1998 March;50(1):65-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

  XIV CONGRESS OF THE SOCIETA' ITALIANA DI NEFROLOGIA SEZIONE PIEMONTE-VALLE D'AOSTA
(Ivrea, October 5, 1996)


Minerva Urologica e Nefrologica 1998 March;50(1):65-9

language: Italian

Comorbidity factors in the Dialysis Registries of different countries and in the Piedmont Registry

Giachino G. 1, Jadarola A. M. 2, Chiappero F. 1, Saltarelli M. 1, Rosati C. 1, Salomone M. 3, Piccoli G. B. 2

1 Ospedale di Rivoli (Torino), Divisione e Servizio di Nefrologia e Dialisi;
2 Ospedale Molinette - Torino, Divisione e Servizio di Nefrologia e Dialisi;
3 Ospedale Valletta - Torino, Divisione e Servizio di Nefrologia e Dialisi


PDF  


The parameters used at present by the Dialysis and Transplant Registries of various countries to evaluate dialyzed patients’ comorbidity show great differences, mostly owing to the different epidemiological, social and racial characteristics of the studied populations. Moreover, the typology of the dialyzed patient is changing: the mean age is increasing, patients with high-risk conditions as vasculopathy and diabetes are widely accepted to the treatment. Thus the Piedmont Registry will be implemented as follows: new fields about comorbidity for clinical (blindness, cachexy and dementia), social (smoking, alchool and drugs addiction) and diagnostic (type of diabetes, of neoplasm, of cardiovascular problem) parameters, and questions needing dichotomic response (vasculopathy yes or no) will be added. The exact time of appearance of any risk factor will be requested, and a field for “others” risk factors will be added as well, trying to deeply identificate the dialytic population not affected by any comorbidity factor. Finally, a new improved control system of the collected data will be used: our registry needs to be implemented in the future by such evaluations, to go on giving useful informations about epidemiology of the dialiyzed patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail